Nestlé Health Science Acquires Majority Stake in Vital Proteins

Yellow Wood Partners to Acquire Nestlé Holistic Health Vitamins, Minerals and Supplements Platform for $1B

September 1, 2026

Consumer Products

Yellow Wood Partners agreed to acquire Nestlé’s Holistic Health platform, a vitamins, minerals and supplements (VMS) business, for $1.0 billion. The transaction covers multiple established brands (including Nature’s Bounty, Nuun, Osteo Bi-Flex, and Gard) and related U.S. private-label supplements plus dedicated manufacturing, packaging, warehousing and distribution operations. The deal is expected to close in the first half of 2027, subject to regulatory approvals.

Lactalis Acquires Protein Works

June 2, 2026

Consumer Products

French dairy group Lactalis has acquired UK-based nutrition brand Protein Works to accelerate its expansion in protein-rich foods, sports nutrition, wellness products, and meal replacements. The deal provides Lactalis with Protein Works’ established consumer brand and direct-to-consumer capabilities, while Protein Works’ team and employees are joining the Lactalis Group. Financial terms were not disclosed.

Nestlé Health Science Acquires Majority Stake in Orgain

February 2, 2022

Food & Beverage

Nestlé Health Science has agreed to acquire a majority stake in Orgain, the U.S. plant-based nutrition company, from founder Dr. Andrew Abraham and Butterfly Equity; both sellers will retain minority ownership positions. Dr. Andrew Abraham will remain CEO of Orgain and the deal will let Nestlé Health Science expand its portfolio of clean, plant-based nutrition products globally; the transaction is subject to customary regulatory approvals.

Nestlé Acquires The Bountiful Company's Core Vitamin Brands for $5.75B

August 9, 2021

Food & Beverage

Nestlé (via Nestlé Health Science) agreed to acquire the core vitamin and supplement brands of The Bountiful Company from KKR and Carlyle for $5.75 billion, integrating brands such as Nature's Bounty, Solgar, Puritan's Pride and Osteo Bi‑Flex into its NHSc portfolio. The deal (expected/closed in H2 2021) brings roughly 4,000–4,500 employees into Nestlé Health Science and establishes Nestlé as a global leader in vitamins, minerals and nutritional supplements across mass retail, specialty retail and e‑commerce.

Nestlé Health Science to Acquire Nuun (TSG Consumer Partners Stake Sale)

May 10, 2021

Healthcare Services

TSG Consumer Partners’ partner company Nuun has entered into an agreement to be acquired by Nestlé Health Science. Terms were not disclosed, and the transaction is expected to close in the second half of 2021.

Nestlé Health Science / Société des Produits Nestlé S.A. to acquire Aimmune Therapeutics

August 31, 2020

Pharmaceuticals

Nestlé Health Science (NHSc), via a Nestlé S.A. acquisition subsidiary (Société des Produits Nestlé S.A.), agreed to acquire Aimmune Therapeutics for USD34.50 per share in cash, valuing the company at approximately USD2.6 billion. NHSc already owned ~25.6% of Aimmune; the tender offer is expected to close in Q4 2020 and will expand Nestlé's portfolio with Aimmune's FDA-approved peanut allergy therapy Palforzia.